GAPDH and cardiac hypertrophy: To further validate the crucial role of glycolysis in the treated cardiomyocytes, significant reductions were observed in key metabolic markers such as LA, PA, G6P, the NAD+/NADH ratio, the activity of GAPDH, and ATP production in AngII‐induced cardiac hypertrophy.